Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.
D000818:Animals; D001665:Binding Sites; D001682:Biological Availability; D001711:Biotransformation; D002994:Clofibrate / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D000960:Hypolipidemic Agents / Q000097:blood / Q000378:metabolism*; D007408:Intestinal Absorption; D007674:Kidney Diseases / Q000378:metabolism; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009525:Niacin / Q000378:metabolism; D011485:Protein Binding; D013045:Species Specificity; D014018:Tissue Distribution
D000960:Hypolipidemic Agents; D009525:Niacin; D006899:Mixed Function Oxygenases; D002994:Clofibrate